Cross-institution positioning
Apr 29, 2026Reduction leaning. 1 reducing, 1 exited across 2 comparable institutions.
Source: Schedule 13 researchCINTAS CORP
Latest stored close $201.12 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Reduction leaning. 1 reducing, 1 exited across 2 comparable institutions.
Source: Schedule 13 research1 increased/new, 1 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 2 sales by 2 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/55 non-amendment material events in the last 90 days; Latest classified evidence: Other event. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +10.9% YoY; Net income +12.3% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 65% through its reported 52-week range; -0.4% over one year.
Source: Stored historical price seriesFiled Apr 29, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Barstad Melanie W. | AGrant, award, or other acquisition · derivative | Phantom Stock Units | 12 | $198.95 | Direct | Sep 17, 2026 |
| Sep 15, 2026 | CARNAHAN KAREN L | AGrant, award, or other acquisition · derivative | Phantom Stock Units | 18 | $198.95 | Direct | Sep 17, 2026 |
| Sep 15, 2026 | Coletti Robert E. | AGrant, award, or other acquisition · derivative | Phantom Stock Units | 30 | $198.95 | Direct | Sep 17, 2026 |
| Sep 15, 2026 | TYSOE RONALD W | AGrant, award, or other acquisition · derivative | Phantom Stock Units | 102 | $198.95 | Direct | Sep 17, 2026 |
| Aug 10, 2026 | Rozakis Jim | FTax/price withholding or payment · amendment | Common Stock | 4.0K | $202.71 | Direct | Aug 13, 2026 |
| Aug 10, 2026 | Rozakis Jim | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 6.0K | $0.00 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Rozakis Jim | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 36.0K | $0.00 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Rozakis Jim | FTax/price withholding or payment | Common Stock | 3.6K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Rozakis Jim | AGrant, award, or other acquisition | Common Stock | 555 | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Rozakis Jim | AGrant, award, or other acquisition | Common Stock | 10.7K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Denton David Brock | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 4.4K | $0.00 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Denton David Brock | AGrant, award, or other acquisition · derivative | Stock Option (Right to Buy) | 18.0K | $0.00 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Denton David Brock | FTax/price withholding or payment | Common Stock | 3.5K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Denton David Brock | AGrant, award, or other acquisition | Common Stock | 370 | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Denton David Brock | AGrant, award, or other acquisition | Common Stock | 5.3K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Garula Scott | FTax/price withholding or payment | Common Stock | 3.0K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Garula Scott | AGrant, award, or other acquisition | Common Stock | 10.7K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | FARMER SCOTT D | FTax/price withholding or payment | Common Stock | 15.9K | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | FARMER SCOTT D | AGrant, award, or other acquisition | Common Stock | 830 | $202.71 | Direct | Aug 12, 2026 |
| Aug 10, 2026 | Schneider Todd M. | FTax/price withholding or payment | Common Stock | 35.6K | $202.71 | Direct | Aug 12, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 6, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Sep 23, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Aug 27, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Aug 3, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Jul 15, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jun 12, 2026 | 8-K | 8.01 | Other event | — | Filing |
| May 11, 2026 | 424B3 | — | Prospectus filing | Capital-related | Filing |
| Mar 31, 2026 | 8-K | 1.01, 1.02, 2.03, 9.01 | Material definitive agreement; Termination of material agreement; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Mar 25, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Mar 11, 2026 | 8-K | 1.01, 7.01, 8.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Dec 22, 2025 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Dec 18, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Aug 31, 2026 | $3.0B | +10.9% |
| Ended Feb 28, 2026 | $2.8B | +8.9% |
| Ended Nov 30, 2025 | $2.8B | +9.3% |
| Ended Aug 31, 2025 | $2.7B | +8.7% |
| Period | Revenue | YoY |
|---|---|---|
| Ended May 31, 2026 | $11.3B | +8.9% |
| Ended May 31, 2025 | $10.3B | +7.7% |
| Ended May 31, 2024 | $9.6B | +8.9% |
| Ended May 31, 2023 | $8.8B | +12.2% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 22.2M | $201.12 | |||
| Vanguard Capital Management CIK0002100119 | Mar 31, 2026 observed Apr 29, 2026 filed · 29d Initial Schedule 13G | Initial Schedule 13G | 25.5M | 6.36% | $169.14 | $173.95 | $201.12 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 26, 2026 filed · 13d Schedule 13G amendment | Exit below reporting threshold | 0 -10.3M | 0.00% -10.16 pts | $194.28 | $168.85 | $201.12 |
Compare CTAS with other securities showing similar institutional activity or recent accumulation across several tracked institutions.